On May 5, 2023 Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma"), a clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, reported that the company will present at several healthcare industry conferences in May 2023 (Press release, Carisma Therapeutics, MAY 5, 2023, View Source [SID1234631104]). These conferences include:
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
American Society of Gene & Cell Therapy (ASGCT) (Free ASGCT Whitepaper) 26th Annual Meeting 2023
Carisma is giving an oral presentation during the meeting:
Chris Sloas, Ph.D., Senior Scientist, Carisma Therapeutics will give a presentation titled "Engineered Microenvironment Converters (EM-Cs): Macrophages Expressing Synthetic Cytokine Receptors Rebalance Pro-/Anti-Inflammatory Signals in Disease Microenvironments"
Friday, May 19, 2023 at 5:15 pm PST
Carisma will also present two abstracts during the meeting:
Pre-clinical development of CT-1119, a mesothelin-targeting chimeric antigen receptor macrophage poster
A Phase 1, First in Human (FIH) Study of Autologous Anti-HER2 Chimeric Antigen Receptor Macrophage (CAR-M) in Participants(pt) with HER2 Overexpressing Solid Tumors Trials in Progress Poster
Michael Klichinsky, Pharm.D., Ph.D., Co-Founder & Chief Scientific Officer will give a presentation titled "Beyond T-cells: CAR-Macs, CAR-NKs."
Tuesday, May 16, 2023 at 10:45 am PST
Tuesday, May 16 to Saturday, May 20, 2023
Los Angeles, California
PEGS Boston Summit
Nicholas Minutolo, Ph.D., Head of Protein Engineering, will give a presentation titled "Advances in CAR-M Cellular Immunotherapy" during the meeting.
Wednesday, May 17, 2023 at 3:05 pm EDT
Boston, Massachusetts
Myeloid Network Seminar Series
Michael Klichinsky, Pharm.D., Ph.D., Co-Founder & Chief Scientific Officer, will give a presentation titled "Genetically engineering macrophages: CAR-M and Beyond."
Thursday, May 11, 2023 at 11:00 am EDT
Virtual
A replay of webcasts, when available, will be posted and archived at Carisma’s Investor Events webpage for a limited time following the event.